Stock Info Nets

Independent Financial Information Made Easy

Our AI creates

The Best Stock Graphs and Charts

Youtube Subscribe Blog GamificArt

The development of Artificial Intelligence (AI) is modifying the way investments are evaluated. We programmed an artificial intelligence (A.I.) to summarize the whole internet. Whether you’re trying to make money investing online, making financial decisions or just getting informed about Wall Street, this page is a way to get informed without reading hundred of pages. Our stock market summary graphs are produced using machine learning, an unbiased view to capture what internet is saying. Usually, the AI reads several hundred pages and summarize it to a short text and several charts.

General Description

BioNTech SE

Youtube Subscribe

...

Ticker: BNTX

Sector: Biotechnology

BioNTech SE develops and commercializes immunotherapies for cancer and other infectious diseases. FixVac product candidates are in Phase II clinical trials for advanced melanoma, including BNT111, BNT112, BN111.
...
...
Extended Summary

BioNTech SE

BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II clinical trial to treat HPV 16+ head and neck cancers; BNT115, which is in Phase I clinical trial in ovarian cancer; and BNT116, which is in Phase I clinical trial for non-small cell lung cancer. It also develops BNT122, which is in Phase II clinical trial for first-line melanoma and in Phase I clinical trial to treat multiple solid tumors; BNT131 that is in Phase I clinical trial for multiple solid tumors; and BNT141 and BNT142 that are in Phase I clinical trial to treat multiple solid tumors. In addition, the company develops BNT151, BNT152, and BNT153 to treat solid tumors; BNT211 to treat multiple solid tumors, and BNT221 for pancreatic and other cancers; BNT311 which are in Phase II clinical trial to treat metastatic non-small cell lung cancer and Phase I clinical trial to treat multiple solid tumors; and BNT312, which is in Phase I clinical trial to treat multiple solid tumors, as well as ONC-392, which is in Phase II clinical trial to treat ovarian cancer and Phase I clinical trial to treat multiple solid tumors. Further, it develops BNT321, an IgG1 monoclonal antibody in Phase I clinical trial for pancreatic cancer; BNT411, a small molecule immunomodulator product candidate in Phase I clinical trial for solid tumors; BNT322, which is in Phase I clinical trial for multiple solid tumors; and prophylactic vaccine for shingles, malaria, tuberculosis, HSV-2, and other infectious diseases. The company has collaborations with Genentech, Inc.; Sanofi S.A.; Genmab A/S; Pfizer Inc.; Shanghai Fosun Pharmaceutical (Group) Co., Ltd; and Ryvu Therapeutics S.A. BioNTech SE was incorporated in 2008 and is based in Mainz, Germany.

Related Results

...
March 12, 2024 22:50 (London Time)

BioNTech SE

BioNTech is a biotechnology company that develops and commercializes immunotherapies for cancer and other infectious diseases. Class-action lawsuit …
Sector: Biotechnology
Ticker: BNTX
Sentiment: -0.9946
MarketCap: 22,892,002,650.0
High: 96.99 Low: 94.8

Open: 96.82 Close: 95.73 Change: -1.09

Read more →
...
March 02, 2024 8:21 (London Time)

BioNTech SE

Shareholders of BioNTech SE (BNTX) should contact Levi & Korsinksky about pending Class Action Suit seeking to learn about a potential recovery unde…
Sector: Biotechnology
Ticker: BNTX
Sentiment: -0.9828
MarketCap: 21,617,847,570.0
High: 92.31 Low: 89.46

Open: 89.7 Close: 90.94 Change: 1.24

Read more →
...
February 29, 2024 6:42 (London Time)

BioNTech SE

The BioNTech SE ADR BNTX slipped 1.47% to $91.43 Wednesday, on what proved to be an all-around grim trading session for the stock market. S&P 500 In…
Sector: Biotechnology
Ticker: BNTX
Sentiment: -0.9881
MarketCap: 21,734,328,165.0
High: 92.76 Low: 91.19

Open: 91.68 Close: 91.43 Change: -0.25

Read more →
...
November 23, 2023 20:48 (London Time)

BioNTech SE

European Patent office declares Moderna mRNA patent invalid. Pfizer/BioNTech has initiated its application to the US Food and Drug Administration fo…
Sector: Biotechnology
Ticker: BNTX
Sentiment: 0.9694
MarketCap: 23,286,610,380.0
High: 98.34 Low: 96.5

Open: 97.21 Close: 97.96 Change: 0.75

Read more →
...
October 21, 2023 8:54 (London Time)

BioNTech SE

Pomerantz LLP is investigating claims on behalf of investors of BioNTech SE. Pfizer Canada ULC has authorized the companies Omicron XBB.1.5-Adapted …
Sector: Biotechnology
Ticker: BNTX
Sentiment: -0.8402
MarketCap: 21,785,607,234.0
High: 92.32 Low: 90.15

Open: 91.88 Close: 90.91 Change: -0.97

Read more →
...
June 26, 2023 10:36 (London Time)

BioNTech SE

North Korea attempted to hack the computer systems of pharmaceutical giant Pfizer to find information on its vaccine. Senegal and Rwanda have signed…
Sector: Biotechnology
Ticker: BNTX
Sentiment: 0.8977
MarketCap: 25,817,312,157.0
High: 107.81 Low: 105.55

Open: 106.87 Close: 107.14 Change: 0.27

Read more →
...
March 12, 2024 22:30 (London Time)

BioNTech SE

Stock of BioNTech SE (BNTX) is gaining over 5 percent on Monday following the announcement of presentation of clinical data updates regarding its in…
Sector: Biotechnology
Ticker: BNTX
Sentiment: -0.9949
MarketCap: 22,892,002,650.0
High: 96.99 Low: 94.8

Open: 96.82 Close: 95.73 Change: -1.09

Read more →
...
March 01, 2024 22:06 (London Time)

BioNTech SE

Accesswire lost money on BioNTech SE (BNTX)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky. BioNTec SE ADr shed 2.70% to $88.96…
Sector: Biotechnology
Ticker: BNTX
Sentiment: -0.9823
MarketCap: 21,147,170,880.0
High: 92.31 Low: 89.46

Open: 89.7 Close: 90.94 Change: 1.24

Read more →
...
January 19, 2024 15:40 (London Time)

BioNTech SE

The BioNTech SE ADR BNTX slipped 1.98% to $97.60 Wednesday, on what proved to be an all-around poor trading session for the stock market. Levi & Kor…
Sector: Biotechnology
Ticker: BNTX
Sentiment: -0.9601
MarketCap: 23,184,392,715.0
High: 97.84 Low: 95.9

Open: 97.3 Close: 97.48 Change: 0.18

Read more →
...
November 12, 2023 11:42 (London Time)

BioNTech SE

Investors of BioNTech include Coalition for Epidemic Preparedness Innovations, Temasek, Bill & Melinda Gates Foundation, Sanofi, Pfizer and 10 more.…
Sector: Biotechnology
Ticker: BNTX
Sentiment: 0.9397
MarketCap: 23,666,955,180.0
High: 100.58 Low: 97.77

Open: 99.3 Close: 99.56 Change: 0.26

Read more →
...
September 21, 2023 0:42 (London Time)

BioNTech SE

Pfizer/BioNTechs updated COVID vaccine to treat new variants gets CHMP recommendation use in Europe. Updated vaccines use the same mRNA technology t…
Sector: Biotechnology
Ticker: BNTX
Sentiment: 0.949
MarketCap: 26,477,928,757.0
High: 110.79 Low: 108.58

Open: 110.79 Close: 108.61 Change: -2.18

Read more →
...
April 28, 2023 14:22 (London Time)

BioNTech SE

&Profund Advisors LLC has purchased a new stake in shares of BioNTech SE, a NASDAQ-listed company, during the fourth quarter. The German-based biote…
Sector: Biotechnology
Ticker: BNTX
Sentiment: 0.9565
MarketCap: 26,867,216,384
High: 111.49 Low: 109.81

Open: 110.69 Close: 111.49 Change: 0.79

Read more →
Search
Happening Now
Categories